BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610
40 results:

  • 1. Risk factors for massive gastrointestinal bleeding occurrence and mortality: A prospective single-center study.
    Redondo-Cerezo E; Tendero-Peinado C; López-Tobaruela JM; Fernandez-García R; Lancho A; Ortega-Suazo EJ; López-Vico M; Martínez-Cara JG; Jiménez-Rosales R
    Am J Med Sci; 2024 Apr; 367(4):259-267. PubMed ID: 38278359
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
    Grande E; Arranz JÁ; De Santis M; Bamias A; Kikuchi E; Del Muro XG; Park SH; De Giorgi U; Alekseev B; Mencinger M; Izumi K; Schutz FA; Puente J; Li JR; O'Donnell PH; Kalebasty AR; Ye D; Mariathasan S; Bene-Tchaleu F; Bernhard S; Lee C; Davis ID; Galsky MD
    Lancet Oncol; 2024 Jan; 25(1):29-45. PubMed ID: 38101433
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
    Shen Q; Liu YX; He Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma.
    Collins K; Hwang M; Antic T; Paintal A; Argani P; Matoso A; Gopinath A; Baskovich B; Mehra R; Williamson SR; Idrees MT; Barletta JA; Anderson WJ; Hirsch MS; Hornick JL; Acosta AM
    Histopathology; 2022 Nov; 81(5):577-586. PubMed ID: 35971742
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors.
    Gupta S; Folpe AL; Torres-Mora J; Reuter VE; Zuckerman JE; Falk N; Stanton ML; Muthusamy S; Smith SC; Sharma V; Sethi S; Herrera-Hernandez L; Jimenez RE; Cheville JC
    Hum Pathol; 2022 Oct; 128():110-123. PubMed ID: 35926808
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Differentiation between pancreatic metastases from renal cell carcinoma and pancreatic neuroendocrine neoplasm using endoscopic ultrasound.
    Kataoka K; Ishikawa T; Ohno E; Mizutani Y; Iida T; Ishikawa E; Furukawa K; Nakamura M; Honda T; Ishigami M; Kawashima H; Hirooka Y; Fujishiro M
    Pancreatology; 2021 Oct; 21(7):1364-1370. PubMed ID: 34281790
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk of diabetes mellitus in patients with prostate cancer receiving injection therapy: A nationwide population-based propensity score-matched study.
    Lin SY; Lin CL; Chang SS; Chang YH; Hsu WH; Lin CC; Kao CH
    Int J Clin Pract; 2021 Sep; 75(9):e14416. PubMed ID: 34047432
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Robot-assisted partial nephrectomy for high-complexity tumors (PADUA score ≥10): Perioperative, long-term functional and oncologic outcomes.
    Koukourikis P; Alqahtani AA; Almujalhem A; Lee J; Han WK; Rha KH
    Int J Urol; 2021 May; 28(5):554-559. PubMed ID: 33604916
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Tale of 2 Morphologies: Diagnostic Pitfalls in
    Sharma AE; Parilla M; Wanjari P; Segal JP; Antic T
    Int J Surg Pathol; 2021 Feb; 29(1):21-29. PubMed ID: 32886007
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report.
    Zeng Y; Zhang W; Li Z; Zheng Y; Wang Y; Chen G; Qiu L; Ke K; Su X; Cai Z; Liu J; Liu X
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439798
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Summary From the First kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research.
    Choueiri TK; Atkins MB; Bakouny Z; Carlo MI; Drake CG; Jonasch E; Kapur P; Lewis B; Linehan WM; Mitchell MJ; Pal SK; Pels K; Poteat S; Rathmell WK; Rini BI; Signoretti S; Tannir N; Uzzo R; Wood CG; Hammers HJ
    J Natl Cancer Inst; 2021 Mar; 113(3):234-243. PubMed ID: 32359162
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum.
    Xia QY; Wang XT; Fang R; Wang Z; Zhao M; Chen H; Chen N; Teng XD; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Am J Surg Pathol; 2020 Apr; 44(4):477-489. PubMed ID: 31764220
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Renal impairment after ileostomy formation: a frequent event with long-term consequences.
    Fielding A; Woods R; Moosvi SR; Wharton RQ; Speakman CTM; Kapur S; Shaikh I; Hernon JM; Lines SW; Stearns AT
    Colorectal Dis; 2020 Mar; 22(3):269-278. PubMed ID: 31562789
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma with Paneth-like cells: Clinicopathologic, morphologic, immunohistochemical, ultrastructural, and molecular analysis of 13 cases.
    Kojima F; Bulimbasic S; Alaghehbandan R; Martinek P; Vanecek T; Michalova K; Pivovarcikova K; Michal M; Hora M; Murata SI; Sugawara E; Rogala J; Limani R; Hes O
    Ann Diagn Pathol; 2019 Aug; 41():96-101. PubMed ID: 31202196
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [
    Hall LT; Titz B; Baidya N; van der Kolk AG; Robins HI; Otto M; Perlman SB; Weichert JP; Kuo JS
    Mol Imaging Biol; 2020 Apr; 22(2):434-443. PubMed ID: 31183841
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Robot-assisted Partial Nephrectomy for Complex (PADUA Score ≥10) tumors: Techniques and Results from a Multicenter Experience at Four High-volume Centers.
    Buffi NM; Saita A; Lughezzani G; Porter J; Dell'Oglio P; Amparore D; Fiori C; Denaeyer G; Porpiglia F; Mottrie A;
    Eur Urol; 2020 Jan; 77(1):95-100. PubMed ID: 30898407
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.
    Pei J; Cooper H; Flieder DB; Talarchek JN; Al-Saleem T; Uzzo RG; Dulaimi E; Patchefsky AS; Testa JR; Wei S
    Mod Pathol; 2019 May; 32(5):710-716. PubMed ID: 30622287
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.
    He H; Trpkov K; Martinek P; Isikci OT; Maggi-Galuzzi C; Alaghehbandan R; Gill AJ; Tretiakova M; Lopez JI; Williamson SR; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Pivovarcikova K; Michalova K; Slouka D; Prochazkova K; Hora M; Bonert M; Michal M; Hes O
    Virchows Arch; 2018 Dec; 473(6):725-738. PubMed ID: 30232607
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [The translocation carcinoma: A pediatric renal tumor also in adults].
    Bruder E; Moch H
    Pathologe; 2016 Mar; 37(2):159-65. PubMed ID: 26972595
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.